Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in ANIX — Anixa Biosciences Inc

CIK 1595888 NEW YORK, NY
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
11 quarters on record

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Derivatives in ANIX

reported options exposure · as of Jun 30, 2026
CallValue
$37,240
CallShares
13,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in ANIX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $37,240 13,300
2026-03-31 $40,506 15,700
2025-09-30 $33,990 10,300
2025-06-30 $137,939 41,800
2025-03-31 $87,114 30,460
2024-12-31 $66,921 28,846
2024-03-31 $380,402 121,924
2023-12-31 $168,326 43,383
2023-03-31 $265,783 61,810
2021-03-31 $122,115 26,093
2020-09-30 $44,942 18,495